Program overview
Context
Indication: Non Small Cell Lung Cancer
Mechanism: Unknown
Modality: Unknown
Sponsor: Duke University
Registry Stop Signal
Ipilimumab
Ipilimumab is flagged as registry stop signal because public records show a registry stop signal, timeline staleness, operational burden. This is a public-data monitoring signal, not a conclusion about clinical failure, regulatory noncompliance, or sponsor intent.
Scores
Risk-signal summary
Registry: 5/5
Timeline: 2/5
Recruitment burden: 2/5
Results availability: 0/5
Program risk: 4/5
Evidence
Public links
https://clinicaltrials.gov/study/NCT01820754 | https://clinicaltrials.gov/study/NCT04863885 | https://clinicaltrials.gov/study/NCT05200143 | https://clinicaltrials.gov/study/NCT03307616 | https://clinicaltrials.gov/study/NCT01585194 | https://clinicaltrials.gov/study/NCT03340129
Linked trials
Trial-level signal details
| Trial | Status | Timeline | Results | Burden |
|---|---|---|---|---|
| NCT01820754 | Low Signal (COMPLETED) | stale_update_signal | Low Signal | None |
| NCT04863885 | Low Signal (ACTIVE_NOT_RECRUITING) | primary_completion_date_past_signal | long_recruitment_duration_signal | Low Signal | strict_eligibility_signal |
| NCT05200143 | Registry Stop Signal (TERMINATED) | stale_update_signal | Low Signal | rare_population_signal | strict_eligibility_signal |
| NCT03307616 | Low Signal (ACTIVE_NOT_RECRUITING) | long_recruitment_duration_signal | Low Signal | strict_eligibility_signal |
| NCT01585194 | Low Signal (COMPLETED) | stale_update_signal | Low Signal | None |
| NCT03340129 | Low Signal (RECRUITING) | long_recruitment_duration_signal | Low Signal | large_enrollment_target_signal | rare_population_signal |